Wire · opportunities
The AI Revolution-3: MIT Sloan's Rama Ramakrishnan on How AI Is Transforming Research ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 August 2026 · Fusion42 review
AI is significantly transforming research and drug discovery by speeding up the identification of therapeutic compounds, enhancing clinical studies, and lowering time and costs involved in developing new treatments. Rama Ramakrishnan from MIT Sloan highlights AI's role as a collaborative tool improving decision-making and insight generation across scientific disciplines.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
AI is shifting biotech founders from traditional trial-and-error to data-driven drug discovery. You can now build tools that speed clinical decisions or identify new compounds faster, stepping ahead of competitors tied to older methods.
◆ Coverage
1 source · 15 Aug 2026
◆ Related on Wire
◆ Topics